205 related articles for article (PubMed ID: 6419593)
41. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
[TBL] [Abstract][Full Text] [Related]
42. Gold concentrations and toxicity during oral gold treatment with auranofin.
Sharma RP; Smillie J; Palmer DG
Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
[TBL] [Abstract][Full Text] [Related]
43. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
Goebel KM; Storck U
Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
[TBL] [Abstract][Full Text] [Related]
44. Changes of immunological parameters during auranofin treatment in children affected with juvenile chronic arthritis.
Fantini F; Cottafava F; Martini A; Murelli M; Franchini E; D'Errico R; Panzarasa R
Int J Clin Pharmacol Res; 1986; 6(1):61-7. PubMed ID: 3082775
[TBL] [Abstract][Full Text] [Related]
45. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
Wessel J; Davis P
J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
[No Abstract] [Full Text] [Related]
46. Auranofin therapy in rheumatoid arthritis.
Bernhard GC
J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
[TBL] [Abstract][Full Text] [Related]
47. Auranofin: 1 mg or 9 mg? The search for the appropriate dose.
Calin A; Saunders D; Bennett R; Jacox R; Kaplan D; O'Brien W; Paulus HE; Roth S; Weiss T
J Rheumatol Suppl; 1982; 8():146-8. PubMed ID: 6813476
[No Abstract] [Full Text] [Related]
48. Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study.
Garcia-Morteo O; Suarez-Almazor ME; Maldonado-Cocco JA; Cuttica R; Abate S
Clin Rheumatol; 1984 Jun; 3(2):223-7. PubMed ID: 6432407
[TBL] [Abstract][Full Text] [Related]
49. Auranofin in rheumatoid arthritis.
Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB
J Rheumatol Suppl; 1982; 8():137-45. PubMed ID: 6813475
[No Abstract] [Full Text] [Related]
50. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
Davis P; Menard H; Thompson J; Harth M; Beaudet F
J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
[TBL] [Abstract][Full Text] [Related]
51. Proceedings: Therapeutic innovation in rheumatoid arthritis: worldwide auranofin symposium. Montreal, October 20-21, 1981.
J Rheumatol Suppl; 1982; 8():1-209. PubMed ID: 6813471
[No Abstract] [Full Text] [Related]
52. Bronchiolitis in a rheumatoid arthritis patient receiving auranofin.
O'Duffy JD; Luthra HS; Unni KK; Hyatt RE
Arthritis Rheum; 1986 Apr; 29(4):556-9. PubMed ID: 3085683
[TBL] [Abstract][Full Text] [Related]
53. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
Furst DE
Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
[TBL] [Abstract][Full Text] [Related]
54. Auranofin.
Davis P
Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
[TBL] [Abstract][Full Text] [Related]
55. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
Vischer TL
Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924
[TBL] [Abstract][Full Text] [Related]
56. Gold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
Wilson AP; Prouse PJ; Gumpel JM
Ann Rheum Dis; 1984 Jun; 43(3):511-2. PubMed ID: 6430252
[TBL] [Abstract][Full Text] [Related]
57. Initial experience with oral gold salts in the treatment of rheumatoid arthritis in patients followed up for one year.
Lignère GC; Giavarini S; Longatti S
J Int Med Res; 1984; 12(3):193-7. PubMed ID: 6428946
[TBL] [Abstract][Full Text] [Related]
58. Review of auranofin, an oral chrysotherapeutic agent.
Delafuente JC; Osborn TG
Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
[TBL] [Abstract][Full Text] [Related]
59. Gold therapy in patients with systemic lupus erythematosus.
Weisman MH; Albert D; Mueller MR; Zvaifler NJ; Hesketh SA; Shragg GP
Am J Med; 1983 Dec; 75(6A):157-64. PubMed ID: 6419600
[TBL] [Abstract][Full Text] [Related]
60. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
van Riel PL; Gribnau FW; van de Putte LB
J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
